Status:
COMPLETED
Radiomics for Prediction of Long Term Survival and Local Failure After Stereotactic Radiotherapy for Brain Metastases
Lead Sponsor:
Maastricht Radiation Oncology
Conditions:
Metastases, Neoplasm
Eligibility:
All Genders
18+ years
Brief Summary
Published prognostic scores have limitations in prediction of long term survival after stereotactic radiotherapy for brain metastases. Moreover, no validated tools are available for prediction of loca...
Detailed Description
Sensitivity is low for prediction of long term survival of currently available prognostic scores for brain metastases. First the current clinical models will be optimized with a new prognostic model a...
Eligibility Criteria
Inclusion
- Cerebral metastasized patients
Exclusion
- \-
Key Trial Info
Start Date :
May 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 4 2014
Estimated Enrollment :
155 Patients enrolled
Trial Details
Trial ID
NCT02265549
Start Date
May 1 2014
End Date
September 4 2014
Last Update
January 26 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Maastro Clinic
Maastricht, Netherlands, 6229 ET